Company news

Simulations Plus, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Simulations Plus Sets Date for Second Quarter Fiscal Year 2022 Earnings Release and Conference Call

March 21, 2022

Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit National Organization for Rare Disorders

March 16, 2022

Simulations Plus Releases MembranePlus 3.0

March 9, 2022

Simulations Plus Enters New Collaboration with Leading Animal Health Company

January 12, 2022

Simulations Plus Reports First Quarter Fiscal 2022 Financial Results

January 5, 2022

Simulations Plus Sets Date for First Quarter Fiscal Year 2022 Earnings Release and Conference Call

December 19, 2021

Simulations Plus Extends its Distributor Agreement in Japan with Northern Science Consulting for Monolix™

December 1, 2021

Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit, Dispensary of Hope

November 29, 2021

Simulations Plus Names Sharlene Evans to Board of Directors

November 18, 2021

Simulations Plus Releases RENAsym® Version 1A Software for Kidney Injury

November 15, 2021

Simulations Plus Releases GastroPlus® Version 9.8.2

October 27, 2021

Simulations Plus Reports Fourth Quarter and Full Year Fiscal 2021 Results

October 24, 2021

Simulations Plus Announces the University+ Program

October 20, 2021

Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2021 Earnings Release and Conference Call

October 10, 2021

Simulations Plus Receives New Grant Award From the FDA

September 22, 2021

Simulations Plus Releases ADMET Predictor® (X.3)

September 14, 2021

Simulations Plus Reports Continued Success in Second Phase of AIDD Collaboration with Large Pharmaceutical Company

August 18, 2021

Simulations Plus Reports Third Quarter Fiscal 2021 Financial Results

July 11, 2021

Simulations Plus Celebrates 25 Years in Business

July 7, 2021

Simulations Plus Sets Date for Third Quarter Fiscal Year 2021 Earnings Release and Conference Call

June 27, 2021

Simulations Plus Releases IPFsym version 1A, State-of-the-Art Quantitative Systems Pharmacology (QSP) Software for Idiopathic Pulmonary Fibrosis (IPF)

June 16, 2021

Simulations Plus Uplisted to The Nasdaq Global Select Market®

May 11, 2021

Simulations Plus Releases ADMET Predictor® (X.2)

April 26, 2021

U.S. FDA Renews Licenses of DILIsym Software

April 19, 2021

Simulations Plus Reports Record Second Quarter Fiscal 2021 Financial Results

April 11, 2021

Simulations Plus Reports Successful Results from AIDD Collaboration with Large Pharmaceutical Company

April 6, 2021

Simulations Plus Sets Date for Second Quarter Fiscal Year 2021 Earnings Release and Conference Call

March 28, 2021

Simulations Plus Forms Scientific Advisory Board for RENAsym Consortium

March 15, 2021

Simulations Plus Releases GastroPlus® Version 9.8.1

February 8, 2021

Simulations Plus Enters Agreement with Distributor in China

February 1, 2021

Simulations Plus Awards Infrastructure Improvement Grant to Makerere University Department of Pharmacology and Therapeutics

January 13, 2021

Simulations Plus Enters New Funded Collaboration to Improve Lung Exposure Models for Pulmonary Infection Treatments

January 11, 2021

Simulations Plus Reports Record First Quarter FY2021 Financial Results

January 10, 2021

Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus® ACAT™ Model for Oral Absorption of Peptides

January 4, 2021

Simulations Plus Sets Date for First Quarter Fiscal Year 2021 Earnings Release and Conference Call

January 3, 2021

Simulations Plus Publishes its Inaugural Environmental, Social and Governance (ESG) Report

December 15, 2020

Simulations Plus Names Industry Veteran Will Frederick as Chief Financial Officer

November 30, 2020

Simulations Plus Reports FY2020 and Fourth Quarter FY2020 Financial Results

November 15, 2020

Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2020 Earnings Release and Conference Call

November 8, 2020

Simulations Plus Releases GastroPlus® Version 9.8

October 19, 2020

Simulations Plus Announces Quarterly Cash Dividend of $0.06 per Share

October 12, 2020

Simulations Plus Extends Partnership with Large Pharmaceutical Company to Further Expand High-Throughput PBPK Capabilities in ADMET Predictor®

September 28, 2020

Simulations Plus Releases ADMET Predictor® Version 10.0 (APX)

September 14, 2020

Simulations Plus Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

August 9, 2020

Simulations Plus Announces Pricing of $100 Million Underwritten Offering of Common Stock

August 4, 2020

Simulations Plus Announces Proposed Underwritten Public Offering

August 3, 2020

Simulations Plus Reports Third Quarter FY2020 Financial Results

July 8, 2020

Simulations Plus Sets Date for 3rd Quarter 2020 Earnings Release and Conference Call

July 1, 2020

Simulations Plus Receives New Grant Award from the FDA

May 27, 2020

Simulations Plus Reports Record Second Quarter FY2020 Revenue

April 8, 2020

← Newer news releases · Older news releases →

Calls

The 5 newest of 21 calls. Every call is listed under its year.

Decks

The 5 newest of 141 decks. Every deck is listed under its year.